The remit of the Ophthalmology Specialty Group is to support a national portfolio of structured research studies in Ophthalmology and the Vision Sciences. The Group has wide geographical coverage, with 20 of the 25 Comprehensive Local Research Networks having nominated a lead in this specialty group area. The Group are currently seeking to include members with expertise in visual rehabilitation and lay persons particularly from those regions of the UK where there is no existing representation. The main purpose of the Specialty Group is to ensure that high quality clinical research is appropriately nurtured and supported throughout the UK with the specific aim of helping the research community to deliver on its commitments of swift set up, timely recruitment, and delivery of high quality data through efficient management of adopted studies.
The Group’s portfolio includes: Clinical trials involving medicinal products as interventions in diseases of the eye and optic nerve, studies and trials of devices in diseases of the eye and optic nerve, studies and trials of childhood visual disorders, longitudinal observational studies or that documenting natural history and risk factors, genetics and pharmacogenomics of eye diseases.
The Ophthalmology Specialty Group will work closely with the Royal College of Ophthalmologists and other stakeholders, to ensure that new developments in the field of Vision Science are informed by a national clinical research strategy and can be successfully delivered in the NHS setting.
Specialty Group Lead: Professor Chris Hammond
Professor Chris Hammond BA MA BM BCh MRCP (UK) FRCOphth MD is Frost Chair of Clinical Ophthalmology at King’s College London and an NIHR Senior Research Fellow studying the genetics of common age-related eye diseases. Based in KCL’s Department of Twin Research and Genetic Epidemiology at St Thomas’ Hospital, his research has focused on the genetics of myopia, glaucoma, and age-related cataract using –omics technologies including genome-wide association studies, whole-genome sequencing, and epigenetics, and in particular measuring quantitative healthy variation in these traits in 3000-5000 twins. He has also performed twin studies to examine the heritability of macular pigment, dry eye, pupillary responses. As a member of the TwinsUK Resource Executive Committee, he is involved in the management, planning and use of the TwinsUK cohort (PI Prof Tim Spector). Chris has over 70 publications to his name, including four book chapters. He is also a practising ophthalmologist with a special interest in adult strabismus, and paediatric ophthalmology.
After obtaining his BA from Cambridge University and BM BCh from the University of Oxford in 1988, Chris trained in General Medicine in Oxford and Stoke on Trent. His ophthalmology training was started at the Sussex Eye Hospital, Brighton, and Addenbrooke’s Hospital, Cambridge, and he was Registrar at the Western Eye Hospital, Senior Registrar at St Thomas’ Hospital and Fellow at Moorfields Eye Hospital, London. He spent ten years as Consultant Ophthalmologist at Princess Royal University Hospital, Orpington, before being appointed to a chair at King’s College London. Chris was awarded an MD by the University of London in 2000. He is Regional Adviser to the Royal College of Ophthalmologists, South Thames Region and a member of the Ophthalmology National CRN; the Guide Dogs for the Blind Ophthalmic Research Advisory Group; the London Deanery Ophthalmology School Board and Ophthalmology Executive Committee; the College of Optometrists’ Therapeutics Panel; Ophthalmic Epidemiology’s Editorial Board; and the boards of Ophthalmic and Physiological Optics and the Society of Clinical Ophthalmology.
Visit the National Ophthalmology Specialty Group for further information.